Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Pietrantonio F. N Engl J Med 2020;382:876-877.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pietrantonio F. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. N Engl J Med 2020;382:876-877.
PMID: 32101677